Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts. Show more
500 Cummings Center, Beverly, MA, 01915, United States
Market Cap
154.2M
52 Wk Range
$5.34 - $9.13
Previous Close
$5.81
Open
$5.84
Volume
166,075
Day Range
$5.80 - $5.90
Enterprise Value
70.02M
Cash
105.5M
Avg Qtr Burn
N/A
Insider Ownership
12.89%
Institutional Own.
78.95%
Qtr Updated
06/30/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
